Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Oncoinvent Publishes Data Explaining Radspherin ® 's Mechanism of Action

Oncoinvent AS
Posted on: 05 Apr 18
Oncoinvent Publishes Data Explaining Radspherin ® 's Mechanism of Action

PR Newswire

STOCKHOLM, April 5, 2018

STOCKHOLM, April 5, 2018 /PRNewswire/ --

Data describing and explaining Radspherin® 's mechanism of action has been published in the Journal of Labelled Compounds and Radiopharmaceuticals. The data further supports and supplements proof-of-principle preclinical data that the company has previously published.

An open access copy of the article can be downloaded from the Oncoinvent Publications webpage.

For further information, please contact::
Jan A. Alfheim,
Chief Executive Officer 
Cell: +47-46-44-00-45                                                                                                 

IR enquiries:
Ole Peter Nordby,
Chief Financial Officer 
Cell: +47-41-28-71-79 

This information was brought to you by Cision,c2488319

PR Newswire

Last updated on: 05/04/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.